These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25832309)

  • 1. Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.
    Hill C; Nicot P; Piette C; Le Gleut K; Durand G; Toussaint B
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):543-7. PubMed ID: 25832309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domperidone and sudden death.
    Prescrire Int; 2006 Dec; 15(86):226. PubMed ID: 17167933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
    Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
    Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Domperidone and the risk of sudden cardiac death].
    van Roeden SE; Belle-van Meerkerk G; van Tuyl SA; van de Ree MA; Muller AF
    Ned Tijdschr Geneeskd; 2013; 157(45):A6770. PubMed ID: 24191928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone: limited benefits with significant risk for sudden cardiac death.
    Hondeghem LM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
    van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
    Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording.
    Berger F; Saâïd S; van Gelder T; Stricker B; Becker M; van den Bemt P
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1418-1424. PubMed ID: 28924989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T
    Can J Gastroenterol Hepatol; 2016; 2016():2937678. PubMed ID: 27446835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.
    Fife D; Waller J; Kaplan S; Hu P; Phillips S; Oliveria SA; Richarz U
    Clin Drug Investig; 2019 Nov; 39(11):1057-1066. PubMed ID: 31325111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Leelakanok N; Holcombe A; Schweizer ML
    Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label postpartum use of domperidone in Canada: a multidatabase cohort study.
    Moriello C; Paterson JM; Reynier P; Dahl M; Aibibula W; Fisher A; Gamble JM; Kuo IF; Ronksley PE; Winquist B; Filion KB;
    CMAJ Open; 2021; 9(2):E500-E509. PubMed ID: 33990364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
    Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Domperidone: off the market or freely available?].
    Otten MH
    Ned Tijdschr Geneeskd; 2013; 157(45):A6950. PubMed ID: 24191929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone and sudden cardiac death in the elderly due to ventricular arrhythmias in developing countries.
    Razzaq A; Saleem S; Javed H
    J Pak Med Assoc; 2024 Sep; 74(9):1727-1728. PubMed ID: 39279091
    [No Abstract]   [Full Text] [Related]  

  • 19. Domperidone and sudden cardiac death: How much longer should we wait?
    Michaud V; Turgeon J
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):215-7. PubMed ID: 23328387
    [No Abstract]   [Full Text] [Related]  

  • 20. Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis.
    Mehrabadi A; Reynier P; Platt RW; Filion KB
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1316-1324. PubMed ID: 30106193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.